PHARMACY

Drive4COPD achieves record

BY Alaric DeArment

RIDGEFIELD, Conn. — A coalition of companies, celebrities and health organizations has achieved its goal of screening 1 million Americans for risk of chronic obstructive pulmonary disease.

Drive4COPD announced the milestone Wednesday, saying its aim was to change how COPD is addressed in the United States; Drive4COPD identified those at risk through its COPD Population Screener.

COPD, which includes chronic bronchitis and emphysema, is the fourth leading cause of death in the United States.

“For many, taking the brief, five-question screener may be the first indication that they are at risk for COPD,” COPD Alliance chairman Brian Carlin said. “The results of the screener can prompt those at risk to have a conversation with a healthcare professional and, if needed, [to] take steps to prevent irreversible lung damage.”

The coalition also said that it had shared information on COPD with millions of other people, in addition to the 1 million it screened.

“We are thrilled that in just one year, we have already made a mark on reaching the millions of people who may be at risk for COPD,” Boehringer Ingelheim Pharmaceuticals SVP Chris Barrett said. “With our campaign partners, we’ve been able to reach a far greater audience than we ever could have alone, and we welcome other partners to join our mission.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Nestlé Health Sciences completes acquisition of CM&D Pharma

BY Allison Cerra

LUTRY, Switzerland — Nestlé Health Sciences completed its acquisition of a company that develops "medical foods" for such medical conditions as kidney disease, inflammatory bowel disease and colon cancer.

The acquisition of CM&D Pharma comes one month after Nestlé Health Sciences became operational. The company said the acquisition would boost its science-based nutrition ventures. CM&D’s leading product, Fostrap, is a medical food in the form of a chewing gum for kidney patients who have an elevated level of phosphate in the blood, known as hyperphosphatemia.

Financial terms were not disclosed.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

NACDS Foundation unveils application process for Community PREP

BY Allison Cerra

ALEXANDRIA, Va. — In an effort to create 30 new community pharmacy residency positions by funding programs across the nation, the charitable arm of the National Association of Chain Drug Stores announced the grant application, review and approval process for its Community Pharmacy Residency Expansion Project.

The NACDS Foundation said that Community PREP, which first was announced in December 2010, will award 15 grants to nonprofit academic institutions, totaling $50,000 each.

“The NACDS Foundation is pleased to provide this much-needed funding to create and expand community pharmacy residency programs throughout the United States,” NACDS Foundation president Edith Rosato said. “These patient-focused residency programs will help cultivate pharmacy graduates’ abilities to provide innovation in the delivery of patient care services under the expert guidance of community pharmacy preceptors.”

Click here for more information on the Community PREP program.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES